Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases

Journal of the American Society of Nephrology

Volumn 7, Issue 5, 1996, Pages 661-666

  Shulman, Kenneth ^a   Rosen, Seymour ^a   Tognazzi, Kathi ^a   Manseau, Eleanor J ^a   Brown, Lawrence F ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Glomerular permeability; Renal disease; Vascular endothelial growth factor

Indexed keywords

HISTAMINE; MESSENGER RNA; VASCULOTROPIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030357278     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Dvorak HF, Orenstein NS, Carvalho AC, et al.: Induction of a fibrin-gel investment: An early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. J Immunol 1979;122:166-174.
2. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-985.
3. 2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 1990;50:1774-1778.
4. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161:851-858.
5. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989;86:7311-7315.
6. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-1309.
7. Keck PJ, Hauser SD, Krivi G, et al.: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246:1309-1312.
8. Conn G, Bayne ML, Soderman DD, et al.: Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 1990;87:2628-2632.
9. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255: 989-991.
10. Terman BI, Dougher Vermazen M, Carrion ME, et al.: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 1992;187:1579-1586.
11. Brown LF, Berse B, Jackman RW, et al.: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995;26:86-91.
12. Brown LF, Berse B, Jackman RW, et al.: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993;53:4727-4735.
13. Brown LF, Berse B, Jackman RW, et al.: Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993;143:1255-1262.
14. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond) 1992; 359:845-848.
15. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond) 1992;359: 843-845.
16. Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992; 3:211-220.
17. Dvorak HF, Sioussat TM, Brown LF, et al.: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exp Med 1991;174:1275-1278.
18. Senger DR, Perruzzi CA, Feder J, Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986;46:5629-5632.
19. Brown LF, Yeo K-T, Berse B, et al.: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992;176:1375-1379.
20. Brown LF, Olbricht SM, Berse B, et al.: Expression of vascular permeability factor in delayed hypersensitivity skin reactions. J Immunol 1995;154:2801-2807.
21. Brown LF, Harrist TJ, Yeo K-T, et al.: Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 1995;104:744-749.
22. Detmar M, Brown LF, Claffey KP, et al.: Overexpression of vascular permeability factor and its receptors in psoriasis. J Exp Med 1994;180:1141-1146.
23. Fava RA, Olsen NJ, Spencer-Green G, et al.: Vascular permeability factor/endothelial growth factor (VPF/ VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994; 180:341-346.
24. Koch AE, Harlow LA, Haines GK, et al.: Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152: 4149-4156.
25. Brown LF, Berse B, Tognazzi K, et al.: Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 1992;42:1457-1461.
26. Breier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development (Camb) 1992;114:521-532.
27. Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13: 18-32.
28. Sioussat TM, Dvorak HF, Brock TA, Senger DR: Inhibition of vascular permeability factor (vascular endothelial growth factor) with anti-peptide antibodies. Arch Biochem Biophys 1993;301:15-20.
29. ffrench-Constant C, Van De Water L, Dvorak HF, Hynes RO: Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 1989;109:903-914.
30. Tischer E, Mitchell R, Hartman T, et al.: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991;266:11947-11954.
31. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N: Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992;267:26031-26037.